ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "clinical trials and glucocorticoids"

  • Abstract Number: 3141 • 2016 ACR/ARHP Annual Meeting

    Development of a Glucocorticoid Toxicity Index Using Multi-Criteria Decision Analysis

    Eli Miloslavsky1, Raymond P. Naden2, Johannes WJ Bijlsma3, Paul Brogan4, Sherwood Brown5, Paul Brunetta6, Frank Buttgereit7, Hyon K. Choi8, Jean-Francois Dicaire9, Jeffrey Gelfand10, Liam Heaney11, Liz Lightstone12, Leo Lu13, Dedee Murrell14, Michelle Petri15, James T. Rosenbaum16, Kenneth Saag17, Murray Urowitz18, Kevin L Winthrop19 and John H. Stone20, 1Division of Rheumatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2New Zealand Ministry of Health, New Zealand Ministry of Health, Auckland, New Zealand, 3ARC, Amsterdam, Netherlands, 4Department of Paediatric Rheumatology, UCL Institute of Child Health and Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom, 5Psychiatry, UT Southwestern Medical Center, Dallas, TX, 6Genentech, Inc., South San Francisco, CA, 7Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Berlin, Germany, 8Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 9Pinnacle Inc., Quebec, QC, Canada, 10Neurology, University of California San Francisco, San Francisco, CA, 11Department of Respiratory Medicine, Queen's University Belfast, Belfast, Ireland, 12Department of Medicine, Imperial College London, London, England, 13Allergy, Immunology, and Rheumatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 14Department of Dermatology, University of New South Wales, Sydney, Australia, 15Rheumatology Division, Johns Hopkins University School of Medicine, Baltimore, MD, 16Oregon Health & Science University, Portland, OR, 17Division of Clinical Immunology and Rheumatology, University of Alabama Birmingham School of Medicine, Birmingham, AL, 18Medicine, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 19Oregon Health and Sciences University, Portland, OR, 20Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA

    Background/Purpose: Glucocorticoids (GC) are associated with substantial treatment morbidity.  New immunomodulatory agents offer the possibility of limiting GC exposure.  To assess the comparative benefits of…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences